Patients Coming Off Anti-Obesity Injections Regain Pounds at a Quadrupled Rate Compared to Dieters

Fresh analysis reveals that patients who stop using blockbuster slimming jabs like Mounjaro or Wegovy can put back on reduced body mass much more quickly than those who stop traditional lifestyle plans.

Research printed in a prominent health publication shows that while overweight individuals can lose a large proportion of their body weight while undergoing treatment, the weight comes back at an average rate of nearly a kilo each month after stopping.

"Individuals purchasing such treatments should be cognizant of the risk of fast rebound weight gain when the medication is stopped," stated researcher Dr. Susan Jebb.

That rate of regain suggests a reversion to starting weight in about a year and a half.

Weighing Approaches

The study, which examined dozens of trials involving over 9,000 of patients, compared the results of the injectable medications with older methods.

Scientists note that people who shed pounds through diet and exercise generally see a slower weight regain—approximately 100 grams monthly—once they finish.

The Reason for the Quick Regain

Doctors propose the mechanism of the drugs is key to understanding the amplified regain.

The injections copy a body's own chemical called GLP-1, which moderates hunger.

"Artificially providing the hormone concentrations far above than normal may cause the body to produce less of its own natural GLP-1, and may also diminish sensitivity to its effects," explained Dr. Adam Collins, a nutrition expert.

"Stopping of this GLP-1 'fix' results in appetite is no longer kept in check, making binge eating much more probable."

An Ongoing Condition?

Medical guidelines advise the injections for people with obesity-related health risks, accompanied by prescribed lifestyle changes.

Professionals argue that, considering the likelihood of relapse, the therapy is often ongoing.

This opinion is echoed by drug manufacturers, who state that the results "underscore the long-term character of obesity," similar to managing conditions like hypertension.

User Accounts

People who have come off the jabs report a sudden resurgence of cravings.

"I experienced something flipping and I was suddenly starving," described an individual.

The struggle is worsened if patients have not developed sustainable lifestyle or habit modifications during therapy.

Widespread Use

Survey data suggest that millions of adults in the UK have tried weight-loss jabs in the last 12 months, with demand continuing to grow.

• Use is more common among women than men.
• The middle-aged demographic shows the highest usage rates.
• A large proportion obtain the medications through private healthcare rather than the NHS.

Finally, clinicians caution that while these medications are effective agents for shedding pounds, they are not a permanent solution and lasting health benefits likely depends on integrated lifestyle management.